A large real-world study published in 2026 in the journal Inflammatory Bowel Diseases found that GLP-1 use in people with UC and Crohns disease was linked to lower rates of steroid use, hospitalization, and intestinal surgery
It is a peptide, which is a short chain of amino acids
Results Disclaimer: Individual experiences with wellness products vary significantly based on numerous factors, including physiology, lifestyle, expectations, and consistency of use
None of the tested treatments, including GLP-1MK-801, triggered pica behaviour in Wistar rats, indicated by the low consumption of the non-nutritive substance kaolin (Extended Data Fig
Individual timelines vary based on your starting weight, how long you took the medication, and whether you maintained new eating habits after stopping treatment